499 related articles for article (PubMed ID: 10204994)
21. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
22. The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception.
Griesbacher T; Amann R; Sametz W; Diethart S; Juan H
Br J Pharmacol; 1998 Jul; 124(6):1328-34. PubMed ID: 9720808
[TBL] [Abstract][Full Text] [Related]
23. Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).
Gobeil F; Montagne M; Inamura N; Regoli D
Immunopharmacology; 1999 Sep; 43(2-3):179-85. PubMed ID: 10596851
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.
Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D
Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025
[TBL] [Abstract][Full Text] [Related]
25. S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) is a potent and long-acting bradykinin B2 receptor antagonist, in vitro and in vivo.
Félétou M; Robineau P; Lonchampt M; Bonnardel E; Thurieau C; Fauchère JL; Widdowson P; Mahieu JP; Serkiz B; Volland JP
J Pharmacol Exp Ther; 1995 Jun; 273(3):1071-7. PubMed ID: 7791077
[TBL] [Abstract][Full Text] [Related]
26. Autoradiographic localization of [125I-Tyr8]-bradykinin receptor binding sites in the guinea pig spinal cord.
Lopes P; Kar S; Tousignant C; Regoli D; Quirion R; Couture R
Synapse; 1993 Sep; 15(1):48-57. PubMed ID: 8310425
[TBL] [Abstract][Full Text] [Related]
27. Bradykinin receptor subtypes in rat lung: effect of interleukin-1 beta.
Tsukagoshi H; Haddad EB; Barnes PJ; Chung KF
J Pharmacol Exp Ther; 1995 Jun; 273(3):1257-63. PubMed ID: 7791098
[TBL] [Abstract][Full Text] [Related]
28. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin receptors and their antagonists.
Regoli D; Nsa Allogho S; Rizzi A; Gobeil FJ
Eur J Pharmacol; 1998 May; 348(1):1-10. PubMed ID: 9650825
[TBL] [Abstract][Full Text] [Related]
31. Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Rizzi A; Calò G; Amadesi S; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):662-70. PubMed ID: 9402047
[TBL] [Abstract][Full Text] [Related]
32. Lack of specific binding of bradykinin and D-Arg [Hyp3, Thi5, D-Tic, Oic8] bradykinin in membranes from rat heart.
Albus U; Gao X; Greenbaum LM
Agents Actions Suppl; 1992; 38 ( Pt 3)():73-9. PubMed ID: 1334361
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.
Dear JW; Wirth K; Scadding GK; Foreman JC
Br J Pharmacol; 1996 Nov; 119(5):1054-62. PubMed ID: 8922758
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological and functional characterization of bradykinin receptors in rat cultured vascular smooth muscle cells.
Yang CM; Tsai YJ; Pan SL; Wu WB; Wang CC; Lee YS; Lin CC; Huang SC; Chiu CT
Cell Signal; 1999 Dec; 11(12):853-62. PubMed ID: 10659993
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist.
Pruneau D; Paquet JL; Luccarini JM; Defrêne E; Fouchet C; Franck RM; Loillier B; Robert C; Bélichard P; Duclos H; Cremers B; Dodey P
Immunopharmacology; 1999 Sep; 43(2-3):187-94. PubMed ID: 10596852
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
[TBL] [Abstract][Full Text] [Related]
37. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
38. [3H]bradykinin receptor-binding, receptor-recycling, and receptor-internalization of the B2 bradykinin receptor in the murine osteoblast-like cell line MC3T3-E1.
Windischhofer W; Leis HJ
J Bone Miner Res; 1997 Oct; 12(10):1615-25. PubMed ID: 9333122
[TBL] [Abstract][Full Text] [Related]
39. Bradykinin-induced burst of prostaglandin formation in osteoblasts is mediated via B2 bradykinin receptors.
Ljunggren O; Vavrek R; Stewart JM; Lerner UH
J Bone Miner Res; 1991 Aug; 6(8):807-15. PubMed ID: 1664644
[TBL] [Abstract][Full Text] [Related]
40. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
